NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
ID: 350658Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350658

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-051.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated low-risk clinical trials focused on communication disorders through the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative, identified as PAR-24-051, aims to support well-designed research that contributes to the diagnosis, prevention, or treatment of conditions affecting hearing, speech, and language, with trials required to meet specific criteria such as not necessitating FDA oversight and being categorized as low-risk. The funding opportunity is significant for advancing health research and improving public health outcomes related to communication disorders, with a maximum budget of $500,000 in direct costs and a project duration of up to five years. Interested applicants must submit their proposals by January 5, 2024, with subsequent submission cycles until the closing date of January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-051-Full-Announcement.html
    PAR-24-051.html
    The Department of Health and Human Services is issuing a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for investigator-initiated, low-risk clinical trials targeting communication disorders. This initiative, identified as PAR-24-051, invites applications for well-designed research that can contribute significantly to the diagnosis, prevention, or treatment of conditions affecting hearing, speech, and language. The proposed trials must meet specific criteria: they should not necessitate FDA oversight, be categorized as low-risk, and gather data for further investigational studies rather than aiming to change established health policies or standards of care. Application budgets are capped at $500,000 in direct costs, with a maximum project duration of five years. Proposals will undergo a stringent peer review to ensure scientific merit and adherence to NIDCD's mission. The key submission date for new applications is January 5, 2024, with subsequent cycles outlined for the year until the expiration date of January 8, 2028. This funding opportunity aligns with the NIH's broader commitment to advancing health research and enhancing public health outcomes regarding communication disorders.
    Similar Opportunities
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering Clinical Research Center Grants (P50) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human communication disorders. The grants support interdisciplinary research teams focusing on various communication issues, including those related to hearing, balance, smell, taste, voice, speech, and language, with applications permitted for low-risk clinical trials, although they are not mandatory. Eligible applicants include a wide range of institutions such as public and private higher education institutions, nonprofits, and local and state governments, with budgets capped at $1.5 million per year for a maximum project period of five years. Interested parties should submit their applications by October 9, 2024, and can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Early-Stage Dissemination and Implementation Research in Communication Disorders" under the R21 grant mechanism. This initiative aims to support early-stage research projects that enhance the dissemination and implementation of evidence-based innovations (EBIs) in areas such as hearing, speech, balance, taste, and language, with a focus on addressing barriers to adoption in clinical settings. The funding opportunity will provide approximately $1 million, with individual project budgets capped at $275,000 over a two-year period, and applications are due by October 12, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.
    Dissemination and Implementation Research in Communication Disorders Conference (U13 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is inviting proposals for the organization of an annual conference focused on Dissemination and Implementation (D&I) Research in Communication Disorders. The objective of this cooperative agreement is to enhance the capacity of participants to conduct high-quality D&I research across various domains, including hearing, balance, taste, smell, voice, speech, and language, while promoting diversity and inclusion among attendees. This initiative is critical for advancing the understanding and adoption of evidence-based practices in clinical settings. The total funding available for this opportunity is $100,000, with applications due by October 25, 2024, and funding decisions expected by March 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" aimed at supporting independent research projects that enhance workforce diversity in health-related sciences. This initiative specifically targets Early Stage and New Investigators from diverse backgrounds, particularly those underrepresented in biomedical, clinical, and social sciences, and does not require preliminary data for application submissions. The NIH intends to commit $2.7 million to this program, with individual awards capped at $500,000 per year for a maximum duration of five years. Interested applicants can find more information and application details at the NIH grants website, and they must submit their applications by February 6, 2025, with the application submission opening on January 28, 2024.
    Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Experiences to Enhance Clinician-Scientists' Participation in NIDCD’s Research" under the R25 Clinical Trial Not Allowed grant program. This initiative aims to recruit and prepare clinician researchers, particularly from underrepresented groups, by providing hands-on research experiences and developing scientific skills in areas related to hearing, balance, taste, smell, voice, speech, and language research. The program emphasizes the importance of diversity in participant recruitment and requires an effective evaluation and dissemination plan, with a maximum funding amount of $250,000 per year for projects lasting up to five years. Interested applicants must submit their proposals by October 1, 2024, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support emerging researchers in establishing independent careers in biomedical and behavioral research related to hearing, balance, smell, taste, voice, speech, or language. This grant allows for various project types, including secondary data analysis, small research initiatives, and the development of research methodologies or technologies, with the goal of generating preliminary data for future R01 applications. Eligible applicants include a diverse range of institutions, particularly those serving underrepresented groups, and may request up to $375,000 in direct costs over a three-year period. Applications are due by February 17, 2027, and interested parties can find more information and submission guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) grant. This funding opportunity aims to support projects that address critical needs for clinical trial readiness in rare diseases, specifically by facilitating the development of biomarkers and clinical outcome measures essential for trial design. The initiative is particularly important for advancing research on diseases affecting fewer than 200,000 individuals in the U.S., enhancing the likelihood of successful clinical trials. Applicants can request up to $275,000 over two years, with a submission deadline of October 17, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-159.html.